Cargando…
Exploring the Potential of High-Molar-Activity Samarium-153 for Targeted Radionuclide Therapy with [$^{153}$Sm]Sm-DOTA-TATE
Samarium-153 is a promising theranostic radionuclide, but low molar activities (Am) resulting from its current production route render it unsuitable for targeted radionuclide therapy (TRNT). Recent efforts combining neutron activation of $^{152}$Sm in the SCK CEN BR2 reactor with mass separation at...
Autores principales: | Vermeulen, Koen, Van de Voorde, Michiel, Segers, Charlotte, Coolkens, Amelie, Pérez, Sunay Rodriguez, Daems, Noami, Duchemin, Charlotte, Crabbé, Melissa, Opsomer, Tomas, Vargas, Clarita Saldarriaga, Heinke, Reinhard, Lambert, Laura, Bernerd, Cyril, Burgoyne, Andrew R, Cocolios, Thomas Elias, Stora, Thierry, Ooms, Maarten |
---|---|
Lenguaje: | eng |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://dx.doi.org/10.3390/pharmaceutics14122566 http://cds.cern.ch/record/2849042 |
Ejemplares similares
-
Exploring the Potential of High-Molar-Activity Samarium-153 for Targeted Radionuclide Therapy with [(153)Sm]Sm-DOTA-TATE
por: Vermeulen, Koen, et al.
Publicado: (2022) -
Production of Sm-153 With Very High Specific Activity for Targeted Radionuclide Therapy
por: Van de Voorde, Michiel, et al.
Publicado: (2021) -
Production of Sm-153 With Very High Specific Activity for Targeted Radionuclide Therapy
por: Van de Voorde, Michiel, et al.
Publicado: (2021) -
Preparation and Quality Control of the [(153)Sm]-Samarium Maltolate Complex as a Lanthanide Mobilization Product in Rats
por: Naseri, Zohreh, et al.
Publicado: (2011) -
[(153)Sm]Samarium-labeled FAPI-46 radioligand therapy in a patient with lung metastases of a sarcoma
por: Kratochwil, Clemens, et al.
Publicado: (2021)